Urokinase-type plasminogen activator receptor (uPAR) on tumor-associated macrophages is a marker of poor prognosis in colorectal cancer.
about
Stromal Targets for Fluorescent-Guided Oncologic SurgeryNew Mechanisms of Tumor-Associated Macrophages on Promoting Tumor Progression: Recent Research Advances and Potential Targets for Tumor ImmunotherapyEpithelial and stromal cell urokinase plasminogen activator receptor expression differentially correlates with survival in rectal cancer stages B and C patients.uPAR Expression Pattern in Patients with Urothelial Carcinoma of the Bladder--Possible Clinical Implications.Prognostic role of urokinase plasminogen activator receptor in gastric and colorectal cancer: A systematic review and meta-analysis.uPAR-targeted multimodal tracer for pre- and intraoperative imaging in cancer surgerySerum uPAR as Biomarker in Breast Cancer Recurrence: A Mathematical Model.Tumor-associated macrophages in cancers.Hispolon suppresses migration and invasion of human nasopharyngeal carcinoma cells by inhibiting the urokinase-plasminogen activator through modulation of the Akt signaling pathway.The urokinase plasminogen activation system in gastroesophageal cancer: A systematic review and meta-analysis.Macrophages of M1 phenotype have properties that influence lung cancer cell progression.Prognostic Impact of Urokinase Plasminogen Activator Receptor Expression in Pancreatic Cancer: Malignant Versus Stromal Cells.Inflammatory biomarkers and cancer: CRP and suPAR as markers of incident cancer in patients with serious nonspecific symptoms and signs of cancer.Inflammation and uPAR-Expression in Colorectal Liver Metastases in Relation to Growth Pattern and Neo-adjuvant Therapy.Effect of colorectal cancer-derived extracellular vesicles on the immunophenotype and cytokine secretion profile of monocytes and macrophages.Silencing of uPAR via RNA interference inhibits invasion and migration of oral tongue squamous cell carcinomaCholesterol as an Endogenous ERRα Agonist: A New Perspective to Cancer Treatment
P2860
Q26774497-857ADDEF-5B27-4527-BAE4-75D576F5CCA9Q28072045-6598F0F0-DE86-4D3F-9264-29119BC6A8E9Q35097486-0BC9356F-2482-493D-9864-5EA11D46281BQ35751445-02C3BD57-3E7C-4011-827A-84FDB1503DF3Q35781008-0330E624-12CA-4706-9082-D5A29960E210Q35987322-5481FA9D-E043-40EA-BDF7-832BA6AF5F59Q35990029-1D2E5FD8-D098-456C-8730-141FD132B3DEQ38564735-197130E9-C1A0-45A1-AF84-0269F1FEA16CQ38781428-4A7DBD22-E2A6-470A-A11A-7261D4348132Q38833520-2B44D40F-11E8-470B-B849-D21E994F1B2FQ38866724-3B41E65E-A865-4F17-A172-FE739A1D2826Q39424309-68C19FB0-C4F6-4D54-9476-326682627032Q40258398-D4289AA6-F62D-452E-89B8-AACB1A171EDAQ41978426-6E37B970-7A72-47F9-9FA6-29B49B3BB5B1Q55220333-3396C372-242F-4658-9FE4-04091E37D869Q57165696-02224CB9-05C3-493A-A618-B10D8C620727Q58750511-2F6AAC88-EC41-425D-A93C-B15312447310
P2860
Urokinase-type plasminogen activator receptor (uPAR) on tumor-associated macrophages is a marker of poor prognosis in colorectal cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Urokinase-type plasminogen act ...... rognosis in colorectal cancer.
@ast
Urokinase-type plasminogen act ...... rognosis in colorectal cancer.
@en
type
label
Urokinase-type plasminogen act ...... rognosis in colorectal cancer.
@ast
Urokinase-type plasminogen act ...... rognosis in colorectal cancer.
@en
prefLabel
Urokinase-type plasminogen act ...... rognosis in colorectal cancer.
@ast
Urokinase-type plasminogen act ...... rognosis in colorectal cancer.
@en
P2093
P2860
P50
P356
P1433
P1476
Urokinase-type plasminogen act ...... rognosis in colorectal cancer.
@en
P2093
Danish Study Group on Early Detection of Colorectal Cancer
Gunilla Høyer-Hansen
Ib Jarle Christensen
Jane Preuss Hasselby
Martin Illemann
P2860
P304
P356
10.1002/CAM4.242
P407
P577
2014-05-30T00:00:00Z